4//SEC Filing
RODEN MATTHEW 4
Accession 0001209191-22-036141
CIK 0001808865other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 7:56 PM ET
Size
9.1 KB
Accession
0001209191-22-036141
Insider Transaction Report
Form 4
RODEN MATTHEW
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-09+17,538→ 17,538 totalExercise: $18.78Exp: 2032-06-09→ Common Stock (17,538 underlying)
Footnotes (1)
- [F1]This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 9, 2023 or (b) the next annual meeting of the Issuer's stockholders.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001828130
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 7:56 PM ET
- Size
- 9.1 KB